Lucentis as an Adjuvant Therapy With TTT-ICG Based in Choroidal Melanoma

Clinical trial NCT00680225 · COMPLETED

Trial details

NCT number: NCT00680225
Sponsor: New England Retina Associates
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Choroidal Melanoma

Start date: 2007-09-01
Primary completion: 2012-07-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.